메뉴 건너뛰기




Volumn 19, Issue 4, 2006, Pages 215-220

Potential liability for counterfeit medications

Author keywords

Counterfeit; Drugs; Liability; Pharmaceuticals; Supply chain

Indexed keywords

ILLICIT DRUG;

EID: 33750947105     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190006293517     Document Type: Review
Times cited : (2)

References (28)
  • 2
    • 85083935209 scopus 로고    scopus 로고
    • Fake drugs find their way into Rx supply
    • May 25
    • Kestin S, LaMendola B. Fake drugs find their way into Rx supply. Sun-Sentinel. May 25, 2003:A1.
    • (2003) Sun-Sentinel
    • Kestin, S.1    LaMendola, B.2
  • 3
    • 85047234968 scopus 로고    scopus 로고
    • Trojan drugs: Counterfeit and mislabeled pharmaceuticals in the legitimate market
    • Forthcoming
    • deKieffer D. Trojan drugs: counterfeit and mislabeled pharmaceuticals in the legitimate market. Am J Law Med. Forthcoming.
    • Am J Law Med
    • DeKieffer, D.1
  • 5
    • 33750934952 scopus 로고    scopus 로고
    • Replicastreet.com. Available at: Accessed May 10, 2006
    • Replicastreet.com. Available at: http://www.replicastreet.com Accessed May 10, 2006.
  • 6
    • 33750955297 scopus 로고    scopus 로고
    • August 27, Available at: Accessed May 11, 2006
    • Gilliam C. Eli Lilly sued in diluted cancer drug cases. August 27, 2001. Available at: http://www.cancerpage.com/news/article.asp?id=3238. Accessed May 11, 2006.
    • (2001) Eli Lilly Sued in Diluted Cancer Drug Cases
    • Gilliam, C.1
  • 7
    • 23844487834 scopus 로고    scopus 로고
    • Radiofrequency identification technology: Protecting the drug supply
    • March-April. Available at
    • US Food and Drug Administration. Radiofrequency identification technology: protecting the drug supply. FDA Consumer Magazine. March-April 2005. Available at: http://www.fda.gov/fdac/features/2005/205_rfid.html.
    • (2005) FDA Consumer Magazine
  • 8
    • 33750965089 scopus 로고    scopus 로고
    • USC § 2301(5) (2000)
    • 15 USC § 2301(5) (2000).
  • 9
    • 33748191344 scopus 로고    scopus 로고
    • Available at
    • US Food and Drug Administration. FDA's counterfeit drug task force interim report. 2003. Available at: http://www.fda.gov/oc/initiatives/ counterfeit/report/interim_report.html.
    • (2003) FDA's Counterfeit Drug Task Force Interim Report
  • 11
    • 33748203796 scopus 로고    scopus 로고
    • TheStreet.com. September 6, Available at
    • Davis M. Gray clouds imperil drug firms. TheStreet.com. September 6, 2005. Available at: http://www.thestreet.com/stocks/melissadavid/10240816_2. html.
    • (2005) Gray Clouds Imperil Drug Firms
    • Davis, M.1
  • 12
    • 85045416706 scopus 로고    scopus 로고
    • The economics of pharmaceutical price regulation and importation: Refocusing the debate
    • Forthcoming
    • Vernon JA, Golec JH, Hughen WK. The economics of pharmaceutical price regulation and importation: refocusing the debate. Am J Law Med. Forthcoming.
    • Am J Law Med
    • Vernon, J.A.1    Golec, J.H.2    Hughen, W.K.3
  • 14
    • 8744280543 scopus 로고    scopus 로고
    • Europeans investigate resale of AIDS drugs
    • October 29
    • Crouch G. Europeans investigate resale of AIDS drugs. New York Times. October 29, 2002.
    • (2002) New York Times
    • Crouch, G.1
  • 15
    • 33750947359 scopus 로고    scopus 로고
    • Fagan v AmerisourceBergen Corp, 356 F suppl 2d 198 (EDNY 2004)
    • Fagan v AmerisourceBergen Corp, 356 F suppl 2d 198 (EDNY 2004).
  • 17
    • 33750938510 scopus 로고    scopus 로고
    • Former convicts try a safer venture: Pharmaceuticals
    • May 26
    • LaMendola B, Kestin S. Former convicts try a safer venture: pharmaceuticals. Sun-Sentinel. May 26, 2003:A1.
    • (2003) Sun-Sentinel
    • LaMendola, B.1    Kestin, S.2
  • 18
    • 33750958899 scopus 로고    scopus 로고
    • (October). Available at
    • US Food and Drug Administration. Anti-counterfeiting Drug Initiative, public meeting (October 2003). Available at: http://www.fda.gov/oc/initiatives/ counterfeit/oct2003meeting/panel7.html.
    • (2003) Anti-counterfeiting Drug Initiative, Public Meeting
  • 19
    • 33750932189 scopus 로고    scopus 로고
    • [yourlawyer.com Web site]. March 7, Available at
    • Shafer A. Pharmaceutical cos. to remain in suit [yourlawyer.com Web site]. March 7, 2002. Available at: http://www.yourlawyer.com/articles/read/236.
    • (2002) Pharmaceutical Cos. To Remain in Suit
    • Shafer, A.1
  • 20
    • 33750952134 scopus 로고    scopus 로고
    • 159 F2d 169 (2d Cir) (1947)
    • 159 F2d 169 (2d Cir) (1947).
  • 22
    • 33750942355 scopus 로고    scopus 로고
    • Available at: Accessed May 12, 2006
    • Dangerous doses' impact. Available at: http://www.dangerousdoses.com/ html/impact.html. Accessed May 12, 2006.
    • Dangerous Doses' Impact
  • 23
    • 33750942544 scopus 로고    scopus 로고
    • Available at: Accessed May 11, 2006
    • AmerisourceBergen class action [Lawyers and Settlements Web site]. Available at: http://www.lawyersandsettlements.com/case/amerisource. Accessed May 11, 2006.
    • AmerisourceBergen Class Action
  • 24
    • 33750956604 scopus 로고    scopus 로고
    • Available at: Accessed May 11, 2006
    • Pfizer faces class action lawsuit. Available at: http://www.ryar.org/ news/04-13-06.html. Accessed May 11, 2006.
    • Pfizer Faces Class Action Lawsuit
  • 27
    • 33750958181 scopus 로고    scopus 로고
    • Prescription Drug Marketing Act of 1987
    • March 16
    • Prescription Drug Marketing Act of 1987, 71 Fed Reg 13, 599 (March 16, 2006).
    • (2006) 71 Fed Reg , vol.13 , pp. 599
  • 28
    • 33750947000 scopus 로고    scopus 로고
    • HR 2345, 109th Cong. Available at
    • Tim Fagan's Law, HR 2345, 109th Cong (2005). Available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills& docid=f:h2345ih.txt.
    • (2005) Tim Fagan's Law


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.